Dr. Susan Love Launches Women’s Health Web Site

Publication
Article
OncologyONCOLOGY Vol 14 No 4
Volume 14
Issue 4

At the 1999 San Antonio Breast Cancer Symposium, Dr. Susan Love, noted breast surgeon, author, and patient

At the 1999 San Antonio Breast Cancer Symposium, Dr. Susan Love, noted breast surgeon, author, and patient advocate, announced the launch of her new Internet site, SusanLoveMD.com, focused on Baby Boomer women’s health concerns, with an emphasis on breast cancer.

The site offers in-depth information to assist women and their families in making decisions about breast cancer treatments and other lifestyle choices, such as dealing with menopause. In addition, the web site features comprehensive sections on taking charge of one’s health and living with breast cancer, including information on recurrences, a topic that is seldom addressed. Future plans include discussions on alternative treatments backed by scientific data.

“I am excited about the opportunity to connect with women through the Internet,” said Dr. Love, “I have always believed that each patient is unique, and that information is power for personal decision-making. I hope this site empowers women around the world to make informed choices and ultimately receive better care.”

Frequent Chat Sessions

Leveraging the latest Internet technologies, Dr. Love and other medical experts will host frequent interactive chats. One such session took place during the San Antonio breast cancer meeting.

Monitored bulletin boards are available 24 hours per day for communication among visitors, and Dr. Love and her team will be available for one-on-one e-mail correspondence with SusanLoveMD.com members. A highly anticipated community feature will be up-to-date breakthrough editorials regarding research, recent advances and controversies in the treatment of cancer and mid-life women’s health issues, delivered with Dr. Love’s unique and personal perspective.

Respected for her ability to translate medical jargon into plain English, Dr. Love is well known to the millions of women confronted with breast cancer and menopausal decisions. Recently, she was appointed to the National Cancer Advisory Board by President Clinton. She is the director of the Susan Love MD Breast Cancer Institute in Santa Barbara, California, and an adjunct professor of surgery at University of California, Los Angeles (UCLA). Dr. Love is the co-founder of the National Breast Cancer Coalition (NABCO) and former director of the Revlon/UCLA Breast Center. She is the author of Dr. Susan Love’s Breast Book and Dr. Susan Love’s Hormone Book.

Recent Videos
Heather Zinkin, MD, states that reflexology improved pain from chemotherapy-induced neuropathy in patients undergoing radiotherapy for breast cancer.
Study findings reveal that patients with breast cancer reported overall improvement in their experience when receiving reflexology plus radiotherapy.
Patients undergoing radiotherapy for breast cancer were offered 15-minute nurse-led reflexology sessions to increase energy and reduce stress and pain.
Whole or accelerated partial breast ultra-hypofractionated radiation in older patients with early breast cancer may reduce recurrence with low toxicity.
Ultra-hypofractionated radiation in those 65 years or older with early breast cancer yielded no ipsilateral recurrence after a 10-month follow-up.
The unclear role of hypofractionated radiation in older patients with early breast cancer in prior trials incentivized research for this group.
Patients with HR-positive, HER2-positive breast cancer and high-risk features may derive benefit from ovarian function suppression plus endocrine therapy.
Paolo Tarantino, MD discusses updated breast cancer trial findings presented at ESMO 2024 supporting the use of agents such as T-DXd and ribociclib.
Paolo Tarantino, MD, discusses the potential utility of agents such as datopotamab deruxtecan and enfortumab vedotin in patients with breast cancer.
Paolo Tarantino, MD, highlights strategies related to screening and multidisciplinary collaboration for managing ILD in patients who receive T-DXd.